Italy's Chiesi Farmaceutici has signed a deal with Ontario,
Canada-headquartered Trudell Medical International for the latter's
MDI actuation indicator, designed to make it easuer for asthmatics
to see when their inhaler...
Novartis has paid a US drug delivery company $10 million for an
option to an oral formulation of an injectable drug used to treat
osteoporosis that is currently the subject of litigation with Eli
Lilly.
In the race to develop therapeutics based on RNA interference,
Alnylam Pharmaceuticals has claimed a first with the publication of
a study showing in vivo RNAi-mediated gene silencing in
mammals by a method that potentially can be...
US drug delivery company SCOLR Pharma, announced it has filed a
provisional patent application utilizing the company's patented
amino acid technology for the Controlled Delivery Technology (CDT)
extended release form of ondansetron.
The safety hazards of reconstituting toxic drugs has been addressed
by Baxa, who have launched a dual purpose needle that prevents
environmental contamination that can occur during the process of
changing needles.
Dimensional Dosing Systems has received US Food and Drug
Administration (FDA) approval for over-the-counter use of the
company's insulin dosing technology in clinical trials.
A one-dose, microsphere formulation of azithromycin is as effective
as several days' treatment with other drugs for respiratory tract
infections (RTIs), according to new clinical data.
Bioalliance Pharma, a pharmaceutical company focused on the field
of drug resistance, revealed results of a study that indicated a
new formulation of miconazole administered as a bioadhesive
extended release buccal tablet was more...
OctoPlus, a drug delivery and development company, and InnoCore
Technologies, a supplier of biodegradable polymeric drug delivery
systems, announced a joint collaboration to develop and market a
novel injectable drug delivery platform.
Novis, now with almost half a million readers, last week earned
broad industry recognition with two further publishing awards,
following on from its best publication prize earlier this year.
Nobex has partnered with Biocon of India to accelerate its project
to develop an oral formulation of insulin, to provide a more
patient-friendly alternative to current injectable products for
diabetes.
Drug developer 3M has been given the go ahead to manufacture,
assemble and import investigational medicinal products (IMP) for
clinical trials involving human use in the UK, writes Wai Lang
Chu.
Drug delivery company SCOLR Pharma has signed a deal to manufacture
its candidate decongestant product based on pseudoephedrine,
keeping it on track to start clinical trials early next year.
Novel approaches to administering drugs took a step forward after
Aradigm announced positive trial results in its Intraject
needle-free delivery system, which paves the way for a viable
alternative to the standard needle injection.
Researchers in the US have reported the initial development of a
biodegradable polymeric nanofibre-based antibiotic delivery system,
which promotes the healing process even in hard-to-treat wounds.
Giving patients control of analgesic medications through the use of
controllable pumps improves pain relief, but raises the risk of
harm more than 3.5 times, according to the US Pharmacopeia's Centre
for the Advancement of Patient...
Nanotechnology company pSivida has announced the results of the
BrachySil trial, which has confirmed expectations that the compound
(32P-BioSilicon) is safe and effective at tumour progression and
raises possibilities of an effective...
Novartis Consumer Health is set to become one of the first
companies to launch a pharmaceutical based in the 'film strip'
format, which has become a popular alternative to lozenges and gums
for freshening the breath.
The US Food and Drug Administration will start using a risk-based
approach for prioritising site inspections for certain
pharmaceutical products, the agency has announced in a final report
on its current good manufacturing practice...
Pharmaceutical scientists at Cardiff University, UK, have developed
a new method of delivering drugs for treating breast cancer that
promises to be more effective than current treatments
In a dispute with Stanelco Fibre Optics, Bioprogress Technology has
been awarded outright ownership of a master patent giving it
exclusive rights to the process of making capsules from
non-gelatine materials by means of radio frequency...
Medicated chewing gum company Fertin has launched its Chlorhexidine
therapeutic chewing gum in Singapore, the second chewing gum brand
approved since the country's relaxation of its chewing gum ban.
Yamanouchi Pharmaceutical of Japan has been granted the first
approval - in the Netherlands - for a product based on its
proprietary OCAS drug delivery technology.
Australian nanotechnology company pSivida, which earlier this year
revealed it has designs on the drug delivery market, has created a
wholly owned spin-off diagnostics company, AION Diagnostics.
Emisphere Technologies of the US has entered into a licensing deal
with Swiss drug major Novartis to develop an oral formulation of
recombinant growth hormone, currently administered by injection.
Drug giant Pfizer is planning to buy UK-based drug delivery company
Meridica in a move that it says will bolster its activities in
allergy and respiratory medicine.
A drug delivery device worn like a wristwatch and programmed to
administer doses automatically has been developed by Chrono
Therapeutics and researchers at the University of Basel in
Switzerland.
French drug delivery specialist Novagali has raised €14 million in
a second round of fundraising and says the cash will allow it to
support its development programmes, based on a proprietary emulsion
technology, for up to three years.
Inyx has acquired a Swiss-developed drug delivery technology that
should make it possible to develop inhaled drug therapies with two
or more active compounds, even if they are incompatible or
unstable.
UK drug delivery company SkyePharma has reported net losses down in
the first half of the year, but warned revenues and cash flow will
come under pressure as it moves away from its current
milestone-based revenue model.
Germany's Boehringer Ingelheim has revealed plans to buy a
microtechnology specialist - STEAG microParts - to get full control
of a novel inhaler for drug delivery into the lungs.
BioProgress has had one of its pending patents granted in Europe,
shoring up its intellectual property in the area of 'foamed films'
used for rapid delivery of drugs into the mouth.
Needle free injector specialist Bioject Medical Technologies has
won a new contract to supply its drug vial adaptor product,
designed to make syringe filling completely needle free.
US drug delivery company MAP Pharmaceuticals has raised $30 million
in a second-round stock financing with several top-tier
biotechnology investors and says it will use the proceeds to
progress its inhaled steroid and Tempo Inhaler...
BioProgress, a company specialising in the manufacture of films for
use in drug formulations, has teamed up with encapsulation company
Micap to develop a new type of treatment for those wanting to stop
smoking.
Australian drug delivery company Acrux is hoping to raise A$30
million (€18m) in a float on the Australian Stock Exchange to
support the development of its novel transdermal technology that
does not require the use of adhesive patches...
In-Pharmatechnologist's periodic round-up of personnel moves in the
pharmaceutical sector includes a change in leadership at the
Association of the British Pharmaceutical Industry and a new
managing director at tabletting and...
Drug delivery specialist SkyePharma has decided to press ahead with
the development of new drug products based on an encapsulation
technology developed by fellow UK company Micap.
The race to develop an inhaled formulation of insulin - and provide
the first alternative to injections for the millions of people
worldwide who suffer from diabetes - is getting closer.
BioDelivery Sciences International has entered into a definitive
agreement to acquire all of the capital stock of fellow drug
delivery firm Arius Pharmaceuticals.
Calling the next six months 'a critical period', the US Food and
Drug Administration's Acting Commissioner Lester Crawford has
unveiled a lengthy list of agency priorities, including continued
work on Good Manufacturing...
US firm Altair Nanotechnologies has filed two new patent
applications on its TiNano Spheres drug delivery system, which it
claims can deliver a large amount of drug, improving reaction
rates.
A US-based aerosol drug specialist has signed an agreement with
Switzerland's Phares Drug Delivery for use of a technology that can
improve the delivery of inhalation-therapy drugs and overcome
delivery incompatibility in combination...
Researchers in the UK are developing an oral tuberculosis vaccine
for badgers based on alginate gel beads, which protect the bacteria
from stomach acid until it reaches the intestine. They say the
technology could also work for human...
3M has teamed up with MicroDose Technologies to market a new
metered dose inhaler that should be cheap to produce and deliver a
broad range of compounds.
SkyePharma has completed Phase III testing of a new version of
AstraZeneca's asthma drug Pulmicort (budesonide) that does not use
ozone-depleting chlorofluorocarbon (CFC) propellants.
A case currently going through the European Court of Justice could
have worrying implications for companies that use reformulation and
drug delivery as a way to extend the patented lifespan of their
drugs.
A yeast encapsulation technology developed by UK company Micap is
at the heart of a new strategy for controlling
methicillin-resistant Staphylococcus aureus, the 'superbug'
that is emerging as a major threat in hospitals...
The results of a new clinical trial provide evidence that Durect's
Oradur delivery technology can reduce the risk of misuse or abuse
of narcotic painkillers.
Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....
